82 related articles for article (PubMed ID: 21185886)
1. Loss of striatal dopaminergic terminals during the early stage in response to MPTP injection in C57BL/6 mice.
Muroyama A; Kobayashi S; Mitsumoto Y
Neurosci Res; 2011 Apr; 69(4):352-5. PubMed ID: 21185886
[TBL] [Abstract][Full Text] [Related]
2. H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.
Koga K; Mori A; Ohashi S; Kurihara N; Kitagawa H; Ishikawa M; Mitsumoto Y; Nakai M
Eur J Neurosci; 2006 Feb; 23(4):1077-81. PubMed ID: 16519673
[TBL] [Abstract][Full Text] [Related]
3. Effect of manganese exposure on MPTP neurotoxicities.
Baek SY; Lee MJ; Jung HS; Kim HJ; Lee CR; Yoo C; Lee JH; Lee H; Yoon CS; Kim YH; Park J; Kim JW; Jeon BS; Kim Y
Neurotoxicology; 2003 Aug; 24(4-5):657-65. PubMed ID: 12900079
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
[TBL] [Abstract][Full Text] [Related]
5. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of coenzyme Q₁₀ reduces MPTP-induced loss of dopaminergic nerve terminals in the striatum in mice.
Kobayashi S; Muroyama A; Matsushima H; Yoshimura I; Mitsumoto Y
Neurol Sci; 2012 Feb; 33(1):195-9. PubMed ID: 21598008
[TBL] [Abstract][Full Text] [Related]
7. Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter.
Manning-Boğ AB; Caudle WM; Perez XA; Reaney SH; Paletzki R; Isla MZ; Chou VP; McCormack AL; Miller GW; Langston JW; Gerfen CR; Dimonte DA
Neurobiol Dis; 2007 Aug; 27(2):141-50. PubMed ID: 17560790
[TBL] [Abstract][Full Text] [Related]
8. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Lau YS; Fung YK; Trobough KL; Cashman JR; Wilson JA
Neurotoxicology; 1991; 12(2):189-99. PubMed ID: 1956580
[TBL] [Abstract][Full Text] [Related]
9. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
[TBL] [Abstract][Full Text] [Related]
10. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
[TBL] [Abstract][Full Text] [Related]
11. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
[TBL] [Abstract][Full Text] [Related]
12. Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice.
Khan HA
Neurochem Int; 2010 Nov; 57(5):489-91. PubMed ID: 20619308
[TBL] [Abstract][Full Text] [Related]
13. Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice.
Ookubo M; Yokoyama H; Kato H; Araki T
Mol Cell Endocrinol; 2009 Nov; 311(1-2):62-8. PubMed ID: 19631714
[TBL] [Abstract][Full Text] [Related]
14. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Holmer HK; Keyghobadi M; Moore C; Meshul CK
Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
[TBL] [Abstract][Full Text] [Related]
15. Neurotoxicity in murine striatal dopaminergic pathways following long-term application of low doses of permethrin and MPTP.
Kou J; Bloomquist JR
Toxicol Lett; 2007 Jul; 171(3):154-61. PubMed ID: 17597311
[TBL] [Abstract][Full Text] [Related]
16. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
[TBL] [Abstract][Full Text] [Related]
17. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760
[TBL] [Abstract][Full Text] [Related]
18. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
[TBL] [Abstract][Full Text] [Related]
19. [Study of extracellular concentration of dopamine and its metabolites in mice striatum by a microdialysis technique at intraperitoneal administration of MPTP].
Averkin RG; Korshunov VA; Shchegolevskiĭ NV; Mats VN; Markevich VA; Grigor'ian GA; Bazian AS
Zh Vyssh Nerv Deiat Im I P Pavlova; 2010; 60(1):109-19. PubMed ID: 20352690
[TBL] [Abstract][Full Text] [Related]
20. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Jourdain S; Morissette M; Morin N; Di Paolo T
J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]